File Download
Patent History
- ApplicationUS 12/4485206 2014-09-12
- GrantedUS 20150071933 2015-03-12
Patent Family
Supplementary
-
Citations:
- Appears in Collections:
granted patent: Use of Annexin A3 as a Diagnostic and Prognostic Biomarker and Therapeutic Target for Treating Hepatocellular Carcinoma
| Title | Use of Annexin A3 as a Diagnostic and Prognostic Biomarker and Therapeutic Target for Treating Hepatocellular Carcinoma |
|---|---|
| Granted Patent | US 20150071933 |
| Granted Date | 2015-03-12 |
| Priority Date | 2014-09-12 US 12/4485206 2013-09-12 US 12/1877061P |
| Inventors | |
| Issue Date | 2015 |
| Citation | US Patent US 20150071933. Washington, DC: US Patent and Trademark Office (USPTO), 2015 How to Cite? |
| Abstract | Annexin A3 (ANAX3) is utilized as a biomarker for the diagnosis and prognosis of hepatocellular carcinoma (HCC) and the utilization of a monoclonal antibody against ANXA3 or antisense polynucleotide against ANXA3 mRNA for the suppression or treatment of HCC, alone or in combination with other HCC treatment. Monoclonal antibody against ANXA3 can be administered for the suppression of tumor growth, metastasis, and chemoresistance. |
| Persistent Identifier | http://hdl.handle.net/10722/210549 |
| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2015-06-17T07:04:26Z | - |
| dc.date.available | 2015-06-17T07:04:26Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.citation | US Patent US 20150071933. Washington, DC: US Patent and Trademark Office (USPTO), 2015 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/210549 | - |
| dc.description.abstract | Annexin A3 (ANAX3) is utilized as a biomarker for the diagnosis and prognosis of hepatocellular carcinoma (HCC) and the utilization of a monoclonal antibody against ANXA3 or antisense polynucleotide against ANXA3 mRNA for the suppression or treatment of HCC, alone or in combination with other HCC treatment. Monoclonal antibody against ANXA3 can be administered for the suppression of tumor growth, metastasis, and chemoresistance. | - |
| dc.title | Use of Annexin A3 as a Diagnostic and Prognostic Biomarker and Therapeutic Target for Treating Hepatocellular Carcinoma | - |
| dc.type | Patent | - |
| dc.identifier.authority | MA STEPHANIE KWAI YEE=rp00506 | - |
| dc.identifier.authority | GUAN XIN-YUAN=rp00454 | - |
| dc.description.nature | published_or_final_version | - |
| dc.contributor.inventor | GUAN XIN-YUAN | - |
| dc.contributor.inventor | MA STEPHANIE KWAI YEE | - |
| dc.contributor.inventor | TONG MAN | - |
| patents.identifier.application | US 12/4485206 | - |
| patents.identifier.granted | US 20150071933 | - |
| patents.description.assignee | UNIV HONG KONG [CN] | - |
| patents.description.country | United States of America | - |
| patents.date.granted | 2015-03-12 | - |
| patents.identifier.hkutechid | Onco-2013-00467-1 | - |
| patents.date.application | 2014-09-12 | - |
| patents.date.priority | 2014-09-12 US 12/4485206 | - |
| patents.date.priority | 2013-09-12 US 12/1877061P | - |
| patents.description.cc | us | - |
| patents.relation.family | WO 2015035941 (A1) 2015-03-19 | - |
| patents.description.kind | A1 | - |
| patents.type | Patent_granted | - |